. Targeted therapy has created new hope for treating numerous malignancies for which little has previously existed to offer patients. These therapies are designed to block signal transduction pathways critical for tumor growth and survival. However, those pathways often are involved in normal physiologic functioning that, when inhibited, lead to the potential for significant toxicities. Side effects and toxicities of these agents differ from standard chemotherapy regimens of the past and require new knowledge of those involved in caring for patients. Potential advantages of oral agents are described in Figure 1 .
Issues Impacting Successful Use of Oral Cancer Therapies
Although the prevalence of oral oncology agents is expanding rapidly, many factors impact their successful use. With patients taking these medications away from the clinic, the healthcare team may not be aware of many of these issues. Four areas that impact the use of oral oncology agents include financial issues, patient education, adherence issues, and toxicity management.
Financial Issues
Once the prescription is written for an oral cancer agent, the patient may not be able to fill it without obtaining prior authorization from their insurance provider. Oncology practices may not have individuals in place to assist patients with this process. Delays in obtaining a preauthorization can result in patients not having started medication by the time of their next scheduled appointment. Patients may believe the provider has this information and may not contact the provider to share it.
Copay amounts vary widely. With treatment costs of as much as $10,000 a month, a copayment of even 5% can be prohibitive. Patients may choose to decline the prescription and not notify their healthcare provider until their next visit. Delays may occur as assistance programs are sought. Although some pharmaceutical companies offer assistance via the provision of copay assistance cards, these cards typically are not available to patients on Medi- 
